Quarterly Earnings

Ace Hardware reports record $10 billion in revenue, fueled by digital growth and store expansion, yet a dip in net income points to strategic international changes.

Orion Energy Systems will present its clean tech vision at an upcoming conference. Amid sales dips, can it convince investors of its EV and LED growth?

Struggling lifestyle brand Greenlane appoints DeFi expert Jason Hitchcock as CEO, doubling down on its risky pivot into the Berachain ecosystem.

Bridgemarq Real Estate Services maintains its dividend, but a closer look reveals financial pressures and a high payout ratio in a shifting market.

AI firm Docebo's $60M share buyback is complicated by its majority owner's surprise move and new debt, sparking questions about its strategy.

The research giant took a massive Q4 loss from asset impairments but points to improving client demand and a strategic overhaul as signs of a turnaround.

Riding a wave of innovation and strategic shifts, the cruise wellness leader posts record earnings and projects over $1B in 2026 revenue.

The aluminum giant posts near-record 2025 profits despite market headwinds, unveiling an ambitious plan for growth and increased shareholder returns.

Capstone Copper's 2026 plan reveals massive spending on future projects, but rising costs and stable output sent shares tumbling. Is the bet worth it?

The specialty chemicals firm saw a full-year revenue dip but ended 2025 with strong cash flow and signs of a turnaround in its struggling divisions.

Hecla Mining posts a record $1.4B year, slashes debt, and sells a major gold mine to double down on its strategy to dominate the North American silver market.

RV giant THOR Industries' upcoming Q2 earnings are a critical test for consumer spending as interest rate cuts battle cautious sentiment and market shifts.

With strong growth and a high valuation, BrightSpring's upcoming Investor Day is a key moment to outline its strategy for profitability and market leadership.

The gas giant posts huge profits and production growth in its first year post-merger, charting a course for massive debt reduction and shareholder returns.

As Jazz Pharmaceuticals preps for key investor talks, all eyes are on its blockbuster pipeline, revenue growth, and strategy to fend off competition.

Facing massive revenue declines and a shrinking coach network due to GLP-1 drugs, Medifast bets its future on a risky pivot from weight loss to metabolic health.

With a major earnings call set for Feb. 23, Lincoln Educational Services' 2025 results will reveal if its aggressive expansion meets soaring market demand.

Havas reports 3.1% organic growth, driven by its Converged.AI platform and a series of key acquisitions, positioning it as a tech-forward industry leader.

Following a year of robust earnings and a 10% dividend hike, Great-West Lifeco's CEO is set to detail the firm's future plans in a key investor chat.

As KP Tissue prepares to release Q4 2025 results, all eyes are on Kruger Products' performance after a year of major strategic investments and expansion.